KMKarin Mörl

Karin Mörl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karin Mörl has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular Basis of NPY Recognition and Ligand Selectivity at the Neuropeptide Y 5 Receptor

    by Lisa Christin Peuker, Hongyu Wang, Kun Chen, Kristin Löbner, Karin Mörl, Simon Jonas Schwarz, Qiang Zhao, Beili Wu, Annette Gabriele Beck‐Sickinger

    Neuropeptide Y receptors (YRs) have been demonstrated to mediate physiological functions such as food intake, energy expenditure and mood regulation. Despite the low sequence identity exhibited by the four YR subtypes, Y 1 R, Y 2 R, Y 4 R, and Y 5 R, all of them recognize the endogenous ligand neuropeptide Y (NPY), which demonstrates their complex ligand recognition and activation mechanisms. The Y 5 R is regarded as a promising drug target for cachexia and cancer, but drug development has been hampered by the lack of structural information on ligand‐Y 5 R interactions. We report the cryo‐electron microscopy structure of Y 5 R in complex with NPY and the G i1 protein, revealing unique features of the Y 5 R extracellular regions that participate in ligand recognition and illustrating the specific binding mode of the NPY C‐terminus to Y 5 R. The structural information is supported by mutagenesis studies investigating ligand binding and receptor activation with the endogenous ligand NPY and the selective Y 5 R agonist sY 5 ago. Structural analysis provides valuable insights into the factors driving receptor subtype selectivity, thus offering an opportunity for drug discovery of Y 5 R.

  • Open Access

    Molecular Basis of NPY Recognition and Ligand Selectivity at the Neuropeptide Y 5 Receptor

    by Lisa Christin Peuker, Hongyu Wang, Kun Chen, Kristin Löbner, Karin Mörl, Simon Jonas Schwarz, Qiang Zhao, Beili Wu, Annette Gabriele Beck‐Sickinger

    Neuropeptide Y receptors (YRs) have been demonstrated to mediate physiological functions such as food intake, energy expenditure and mood regulation. Despite the low sequence identity exhibited by the four YR subtypes, Y 1 R, Y 2 R, Y 4 R, and Y 5 R, all of them recognize the endogenous ligand neuropeptide Y (NPY), which demonstrates their complex ligand recognition and activation mechanisms. The Y 5 R is regarded as a promising drug target for cachexia and cancer, but drug development has been hampered by the lack of structural information on ligand‐Y 5 R interactions. We report the cryo‐electron microscopy structure of Y 5 R in complex with NPY and the G i1 protein, revealing unique features of the Y 5 R extracellular regions that participate in ligand recognition and illustrating the specific binding mode of the NPY C‐terminus to Y 5 R. The structural information is supported by mutagenesis studies investigating ligand binding and receptor activation with the endogenous ligand NPY and the selective Y 5 R agonist sY 5 ago. Structural analysis provides valuable insights into the factors driving receptor subtype selectivity, thus offering an opportunity for drug discovery of Y 5 R.

  • Open Access

    Bio-inspired biomaterial coating for enzyme responsive release of antimicrobial peptides

    by Dennis A. Böhner, Karin Mörl, Annette G. Beck-Sickinger


  • Open Access

    Stable Binding of Full‐Length Chemerin Is Driven by Negative Charges in the CMKLR1 N Terminus

    by Kevin Kretschmer, Tristan Zellmann, Karin Mörl, Annette G. Beck‐Sickinger

    The adipokine chemerin is the endogenous ligand of the chemokine‐like receptor 1 (CMKLR1), a member of the family of G protein‐coupled receptors (GPCRs). This protein ligand plays an important role in obesity and inflammatory processes. Stable receptor–ligand interactions are highly relevant for its different physiological effects such as the migration of immune cells towards sites of inflammation. Here, we demonstrate that negative charges in the CMKLR1 N terminus are involved in the formation of strong contacts with a specific positively charged patch at the surface of full‐length chemerin, which is absent in the short nonapeptide agonist chemerin‐9, thus explaining its reduced affinity. Using receptor chimera of G protein‐coupled receptor 1 (GPR1) and CMKLR1, we were able to identify the residues of this interaction and its relevance for stable full‐length chemerin binding. This could help to develop more potent ligands for the treatment of inflammation‐related diseases.


  • Open Access

    Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors

    by Tingting Tang, Qiuxiang Tan, Shuo Han, Anne Diemar, Kristin Löbner, Hongyu Wang, Corinna Schüß, Victoria Behr, Karin Mörl, Mu Wang, et al.

    In response to three highly conserved neuropeptides, neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide (PP), four G protein–coupled receptors mediate multiple essential physiological processes, such as food intake, vasoconstriction, sedation, and memory retention. Here, we report the structures of the human Y 1 , Y 2 , and Y 4 receptors in complex with NPY or PP, and the G i1 protein. These structures reveal distinct binding poses of the peptide upon coupling to different receptors, reflecting the importance of the conformational plasticity of the peptide in recognizing the NPY receptors. The N terminus of the peptide forms extensive interactions with the Y 1 receptor, but not with the Y 2 and Y 4 receptors. Supported by mutagenesis and functional studies, subtype-specific interactions between the receptors and peptides were further observed. These findings provide insight into key factors that govern NPY signal recognition and transduction, and would enable development of selective drugs.